The impact of non-synonymous mutations on miRNA binding sites within the SARS-CoV-2 NSP3 and NSP4 genes.
Autorzy:
Rad SMAH; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. .; Center of Excellence in Immunology and Immune-Mediated Diseases, Chulalongkorn University, Bangkok, Thailand. .; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand. . Wannigama DL; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.; Department of Infectious Diseases and Infection Control, Yamagata Prefectural Central Hospital, Yamagata, Japan.; Center of Excellence in Antimicrobial Resistance and Stewardship Research, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; School of Medicine, Faculty of Health and Medical Sciences, The University of Western Australia, Nedlands, WA, Australia.; Biofilms and Antimicrobial Resistance Consortium of ODA Receiving Countries, The University of Sheffield, Sheffield, UK.; Pathogen Hunter's Research Team, Department of Infectious Diseases and Infection Control, Yamagata Prefectural Central Hospital, Yamagata, Japan.; Yamagata Prefectural University of Health Sciences, Kamiyanagi, Yamagata, 990-2212, Japan. Hirankarn N; Center of Excellence in Immunology and Immune-Mediated Diseases, Chulalongkorn University, Bangkok, Thailand. .; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand. . McLellanAD; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. alex.mclellan@otago.ac.nz.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 07; Vol. 13 (1), pp. 16945. Date of Electronic Publication: 2023 Oct 07.
Anti-Apoptotic c-FLIP Reduces the Anti-Tumour Activity of Chimeric Antigen Receptor T Cells.
Autorzy:
Tan GMY; Department of Microbiology and Immunology, University of Otago, Dunedin 9010, New Zealand.; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L1 1NT, UK. Poudel A; Department of Microbiology and Immunology, University of Otago, Dunedin 9010, New Zealand. Ali Hosseini Rad SM; Department of Microbiology and Immunology, University of Otago, Dunedin 9010, New Zealand.; Kite Pharma, 1800 Stewart St., Santa Monica, CA 90404, USA. McLellanAD; Department of Microbiology and Immunology, University of Otago, Dunedin 9010, New Zealand.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Oct 04; Vol. 14 (19). Date of Electronic Publication: 2022 Oct 04.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
